Michael I. Lerman
Impact in
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Molecular Biology top 0.2%
- Epigenetics and DNA Methylation
- Renal and related cancers
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- Cancer, Hypoxia, and Metabolism 28
- Cancer Genomics and Diagnostics 18
-
- RNA modifications and cancer 34
- Epigenetics and DNA Methylation 30
- Cancer-related gene regulation 23
- Renal and related cancers 18
- Co-authors
- John Dorrance Minna (23 shared papers)Farida Latif (53 shared papers)Berton Zbar (55 shared papers)Eric J. Stanbridge (18 shared papers)William Marston Linehan (17 shared papers)Umberto Saffiotti (3 shared papers)D. Carleton Gajdusek (3 shared papers)O. Wesley McBride (2 shared papers)
- Journals
- Nucleic Acids Research (23 papers)Oncogene (14 papers)Proceedings of the National Academy of Sciences (13 papers)Human Molecular Genetics (10 papers)Human Genetics (7 papers)
- Partner nations
- United StatesSwedenRussia
In The Last Decade
Michael I. Lerman
175 papers receiving 20.8k citations
Michael I. Lerman's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 7.0k
- Molecular Biology 13.2k
- Pulmonary and Respiratory Medicine 5.1k
- Microbiology 115
- Oncology 3.4k
Countries citing papers authored by Michael I. Lerman
This map shows the geographic impact of Michael I. Lerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael I. Lerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael I. Lerman more than expected).
Fields of papers citing papers by Michael I. Lerman
This network shows the impact of papers produced by Michael I. Lerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael I. Lerman. The network helps show where Michael I. Lerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael I. Lerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene Hit paper breakdown → | 1993 | 2409 |
| 2 | Mutations of the VHL tumour suppressor gene in renal carcinoma Hit paper breakdown → | 1994 | 1494 |
| 3 | Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Hit paper breakdown → | 1994 | 1330 |
| 4 | Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Hit paper breakdown → | 1997 | 1295 |
| 5 | Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease Hit paper breakdown → | 1987 | 1149 |
| 6 | Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome Hit paper breakdown → | 2002 | 724 |
| 7 | 2001 | 579 | |
| 8 | Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. | 2003 | 562 |
| 9 | 1989 | 536 | |
| 10 | The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. | 2000 | 475 |
| 11 | 1995 | 473 | |
| 12 | 1996 | 426 | |
| 13 | 2001 | 343 | |
| 14 | 1998 | 341 | |
| 15 | High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. | 2000 | 336 |
| 16 | 1994 | 332 | |
| 17 | 2002 | 323 | |
| 18 | 2001 | 295 | |
| 19 | 2001 | 267 | |
| 20 | 1996 | 222 |
About Michael I. Lerman
Michael I. Lerman is a scholar working on Cancer Research, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 180 papers that have together received 21.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (34 papers), Epigenetics and DNA Methylation (30 papers), Cancer, Hypoxia, and Metabolism (28 papers), Cancer-related Molecular Pathways (24 papers), Cancer-related gene regulation (23 papers), Renal and related cancers (18 papers), Cancer Genomics and Diagnostics (18 papers) and Renal cell carcinoma treatment (17 papers). The work is most often cited by research in Cancer Research (7.0k citations), Molecular Biology (13.2k citations), Pulmonary and Respiratory Medicine (5.1k citations), Microbiology (115 citations) and Oncology (3.4k citations). Michael I. Lerman has collaborated with scholars based in United States, Sweden and Russia. Frequent co-authors include John Dorrance Minna, Farida Latif, Berton Zbar, Eric J. Stanbridge, William Marston Linehan, Umberto Saffiotti, D. Carleton Gajdusek, O. Wesley McBride, Dmitry Goldgaber and Eugene R. Zabarovsky. Their work appears in journals such as Nucleic Acids Research, Oncogene, Proceedings of the National Academy of Sciences, Human Molecular Genetics and Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.